MedTrace Logo

Caudal Versus Intravenous Dexmedetomidine for Supplementation of Caudal Analgesia in Children

NCT01701778 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2018-11-15

No results posted yet for this study

Summary

The purpose of this study is to compare the effects of caudal dexmedetomidine with intravenous dexmedetomidine on caudal levobupivacaine analgesia in children undergoing lower abdominal surgeries.

Conditions

  • Inguinal Hernia
  • Cryptorchidism

Interventions

DRUG

Caudal Dexmedetomidine

Caudal: Levobupivacaine 0.25% 1ml/kg and dexmedetomidine 1µg/kg Intravenous: 10 ml normal saline

DRUG

Intravenous Dexmedetomidine

Caudal: Levobupivacaine 0.25% 1ml/kg Intravenous: dexmedetomidine 1µg/kg

DRUG

Placebo

Caudal: Levobupivacaine 0.25% 1ml/kg Intravenous: 10 ml normal saline

DRUG

sevoflurane

Induction and maintain anaesthesia

Sponsors & Collaborators

  • West China Hospital

    collaborator OTHER

  • Yao Yusheng

    lead OTHER

Principal Investigators

  • Yusheng Yao, M.D. · Fujian Provincial Hospital

  • Yanqing Chen, M.D. · Fujian Provicial Hospital

  • Jin Liu, M.D. · West China Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
5 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2014-01-31
Completion
2014-01-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01701778 on ClinicalTrials.gov